Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Berthold

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Genes, Chromosomes & Cancer|May 15, 2002
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterationsRuediger Spitz, Barbara Hero, Frank Westermann, et al.
Cancer|February 22, 2002
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplificationMatthias Krams, Barbara Hero, Frank Berthold, et al.
The American Journal of Pathology|February 25, 2003
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastomaMatthias Krams, Barbara Hero, Frank Berthold, et al.
Pediatric Blood & Cancer|October 5, 2007
Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trialThorsten Simon, Barbara Hero, Gabriele Benz-Bohm, et al.
BMC Molecular Biology|April 8, 2009
Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastomaHarald Voth, André Oberthuer, Thorsten Simon, et al.
Immunology Letters|May 26, 2004
NK cell depletion diminish tumour-specific B cell responsesMarkus Jensen, Samir Tawadros, Hans-Harald Sedlacek, et al.
Bioinformatics (Oxford, England)|May 30, 2013
A method for finding consensus breakpoints in the cancer genome from copy number dataLaura Toloşi, Jessica Theißen, Konstantin Halachev, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2010
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paragangliomaFerdinand Sudbrock, Matthias Schmidt, Thorsten Simon, et al.
Molecular Cancer Research : MCR|January 4, 2008
Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastomaHarald Voth, André Oberthuer, Thorsten Simon, et al.
Statistics in Medicine|December 16, 2014
Sample size calculation for the one-sample log-rank testRené Schmidt, Robert Kwiecien, Andreas Faldum, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Genes, Chromosomes & Cancer|May 15, 2002
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterationsRuediger Spitz, Barbara Hero, Frank Westermann, et al.
Cancer|February 22, 2002
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplificationMatthias Krams, Barbara Hero, Frank Berthold, et al.
The American Journal of Pathology|February 25, 2003
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastomaMatthias Krams, Barbara Hero, Frank Berthold, et al.
Pediatric Blood & Cancer|October 5, 2007
Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trialThorsten Simon, Barbara Hero, Gabriele Benz-Bohm, et al.
BMC Molecular Biology|April 8, 2009
Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastomaHarald Voth, André Oberthuer, Thorsten Simon, et al.
Immunology Letters|May 26, 2004
NK cell depletion diminish tumour-specific B cell responsesMarkus Jensen, Samir Tawadros, Hans-Harald Sedlacek, et al.
Bioinformatics (Oxford, England)|May 30, 2013
A method for finding consensus breakpoints in the cancer genome from copy number dataLaura Toloşi, Jessica Theißen, Konstantin Halachev, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2010
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paragangliomaFerdinand Sudbrock, Matthias Schmidt, Thorsten Simon, et al.
Molecular Cancer Research : MCR|January 4, 2008
Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastomaHarald Voth, André Oberthuer, Thorsten Simon, et al.
Statistics in Medicine|December 16, 2014
Sample size calculation for the one-sample log-rank testRené Schmidt, Robert Kwiecien, Andreas Faldum, et al.
Pageof 16